Global RNA Targeting Small Molecule Drug Discovery Market Size, Trends & Growth Opportunity, By Indication (Cancer, Infectious Disease, Metabolic Diseases, Neurological Diseases, Others), By End-user (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others), By Region and Forecast till 2030.
Global RNA Targeting Small Molecule Drug Discovery Market.
The global RNA Targeting Small Molecule Drug Discovery market was valued at USD 1.5 billion in 2023 which expected to reach USD 5.1 billion by 2030 at a CAGR 16.53 % from 2023-2030.
Small molecules that can bind to RNA secondary or tertiary structures and change translation patterns, localization, and degradation are known as RNA-targeting small molecules. These chemical compounds have typical pharmacological features (such as Lipinski's rule of five). It is anticipated that the RNA targeting small molecules drug discovery industry would revolutionize the way the healthcare sector now treats a number of ailments. These drugs work by specifically attacking RNA molecules, which are desirable targets for therapeutic development as they are crucial for regulating gene expression.
Market Drivers
The market is anticipated to increase as a result of the rising demand for RNA targeted small molecule therapies due to its capacity to target a variety of illnesses, including cancer, neurological disorders, and genetic abnormalities. In addition, the industry is expanding as a result of improvements in RNA-targeted drug discovery technologies and increased government support for RNA research. However, it is anticipated that the high price of drug development and the difficulty of finding drugs based on RNA will somewhat restrain market expansion.
Impact of COVID-19
The COVID-19 pandemic has a conflicting effect on the development of RNA-targeting small molecule drugs. On the one hand, the pandemic has raised the need for novel methods of treating viral infections, including those caused by RNA viruses. RNA-targeted drugs may be helpful in treating viral infections because they stop viral RNA from reproducing. As a result, creating RNA-targeted medications to treat COVID-19 and other viral infections has gained increased attention.
Market Segmentation
The Global RNA Targeting Small Molecule Drug Discovery Market is segmented into Indication, End-user. By Indication such as Cancer, Infectious Disease, Metabolic Diseases, Neurological Diseases, Others. Further, market is segmented into By End-user such as Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others.
Regional Analysis
Global RNA Targeting Small Molecule Drug Discovery Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the market. The region's high proportion is largely attributable to the existence of numerous leading pharmaceutical and biopharmaceutical companies, including Skyhawk Therapeutics, Inc., Ribometrix, and Arrakis Therapeutics. These companies are equipped with the tools and expertise required to develop and manufacture large-scale RNA-targeted drugs. They are investing a lot of money in the search for drugs that target RNA. Also, they have developed connections with healthcare professionals and regulatory organizations, which are essential for receiving regulatory approval and marketing new products.
Key Players
Various key players are listed in this report such as Accent Therapeutics, Anima Biotech Inc., Arrakis Therapeutics, AstraZeneca, Epics Therapeutics, Expansion Therapeutics, Hoffmann-La Roche Ltd, H3 Biomedicine Inc., PTC Therapeutics, Ribometrix.
Market Taxonomy
By Indication
• Cancer
• Infectious Disease
• Metabolic Diseases
• Neurological Diseases
• Others
By End-user
• Pharmaceutical and Biopharmaceutical Companies
• Academic and Research Institutes
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global RNA Targeting Small Molecule Drug Discovery Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global RNA Targeting Small Molecule Drug Discovery Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global RNA Targeting Small Molecule Drug Discovery Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global RNA Targeting Small Molecule Drug Discovery Market, By Indication
5.1 Y-o-Y Growth Comparison, By Indication
5.2 Global RNA Targeting Small Molecule Drug Discovery Market Share Analysis, By Indication
5.3 Global RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By Indication
5.3.1 Cancer
5.3.2 Infectious Disease
5.3.3 Metabolic Diseases
5.3.4 Neurological Diseases
5.3.5 Others
6 Global RNA Targeting Small Molecule Drug Discovery Market, By End-user
6.1 Y-o-Y Growth Comparison, By End-user
6.2 Global RNA Targeting Small Molecule Drug Discovery Market Share Analysis, By End-user
6.3 Global RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By End-user
6.3. 1 Pharmaceutical and Biopharmaceutical Companies
6.3.2 Academic and Research Institutes
6.3.3 Others
7 Global RNA Targeting Small Molecule Drug Discovery Market, By Region
7.1 Global RNA Targeting Small Molecule Drug Discovery Market Share Analysis, By Region
7.2 Global RNA Targeting Small Molecule Drug Discovery Market Share Analysis, By Region
7.3 Global RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By Region
8 North America RNA Targeting Small Molecule Drug Discovery Market Analysis and Forecast (2023-2030)
8.1 Introduction
8.2 North America RNA Targeting Small Molecule Drug Discovery Market Share Analysis, By Indication
8.3 North America RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By End-user
8.4 North America RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By Country
8.5.1 U.S.
8.6.2 Canada
9.7.3 Mexico
9 Europe RNA Targeting Small Molecule Drug Discovery Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 Europe RNA Targeting Small Molecule Drug Discovery Market Share Analysis, By Indication
9.3 Europe RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By End-user
9.4 Europe RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By Country
9.5.1 Germany
9.6.2 France
9.7.3 UK
9.8.4. Rest of Europe
10 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market Share Analysis, By Indication
10.3 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By End-user
10.4 Asia Pacific RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By Country
10.5.1 China
10.6.2 Japan
10.7.3 India
10.8.4. Rest of Asia Pacific
11 Latin America RNA Targeting Small Molecule Drug Discovery Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Latin America RNA Targeting Small Molecule Drug Discovery Market Share Analysis, By Indication
11.3 Latin America RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By End-user
11.4 Latin America RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, Country
11.5.1. Brazil
11.6.2. Rest of Latin America
12 Middle East RNA Targeting Small Molecule Drug Discovery Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Middle East RNA Targeting Small Molecule Drug Discovery Market Share Analysis, By Indication
12.3 Middle East RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By End-user
12.4 Middle East RNA Targeting Small Molecule Drug Discovery Market Size and Forecast, By Country
12.5.1. Saudi Arabia
12.6.2. UAE
12.7.3. Egypt
12.8.4. Kuwait
12.9.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
14.1 Accent Therapeutics
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2. Anima Biotech Inc.
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. Arrakis Therapeutics
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 AstraZeneca
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Epics Therapeutics
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Expansion Therapeutics
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
